Concepedia

Author

Tsunamasa Watanabe

St. Marianna University School of MedicineORCID

Also Known As

Hiroki Ikeda, T Watanabe, T. Watanabe, T., Watanabe, Tsunamasa WATANABE, Tsunamasa Watanabe, Tsunamasa Watanabe (426382), Tsunamasa watanabe, Watanabe Tsunamasa, Y Minami

163

Publications

3.1K

Citations

29

H-Index

69

Concepts

All Affiliations

St. Marianna University School of MedicineNagoya City UniversityKitasato UniversityOgaki Municipal HospitalNippon Medical School
TW

About

Tsunamasa Watanabe is an author at St. Marianna University School of Medicine specializing in medicine, hepatitis, and viral hepatitis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

19

1.2K

2

Public Health

2

2

61

3

Engineering

1

1

126

4

Health Sciences

1

1

22

5

Natural Sciences

1

1

402

Tsunamasa Watanabe

×

59

Publications

2.7K

Citations

29

H-Index

YearCitations

The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus

Seiichi Sato, Kai Li, Takeshi Kameyama,

Immunity

2014

402

Combined interferon α2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial

Kazuaki Inoue, Kazuhiko Sekiyama, Masaya Yamada,

Journal of Gastroenterology

2003

173

Freeze-dried formulations for in vivo gene delivery of PEGylated polyplex micelles with disulfide crosslinked cores to the liver

Kanjiro Miyata, Yoshinori Kakizawa, Nobuhiro Nishiyama,

Journal of Controlled Release

2005

126

Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection

Hiromitsu Kumada, Tsunamasa Watanabe, Fumitaka Suzuki,

Journal of Gastroenterology

2017

115

Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis

Kazuaki Chayama, Fumitaka Suzuki, Yoshiyasu Karino,

Journal of Gastroenterology

2017

114

Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection

Hidenori Toyoda, Kazuaki Chayama, Fumitaka Suzuki,

Hepatology

2017

112

Evaluation of a cyclophilin inhibitor in hepatitis C virus–infected chimeric mice in vivo†

Kazuaki Inoue, Takuya Umehara, Urs T. Rüegg,

Hepatology

2007

95

Intracellular-diced dsRNA has enhanced efficacy for silencing HCV RNA and overcomes variation in the viral genotype

Tsunamasa Watanabe, Masayuki Sudoh, Makoto Miyagishi,

Gene Therapy

2006

86

Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase

Daniel Q. Huang, Andrew Tran, Ming‐Lun Yeh,

Hepatology

2023

83

Application of a Newly Developed High-Sensitivity HBsAg Chemiluminescent Enzyme Immunoassay for Hepatitis B Patients with HBsAg Seroclearance

Noboru Shinkai, Kentaro Matsuura, Fuminaka Sugauchi,

Journal of Clinical Microbiology

2013

73

Page 1